banner
Inquiry

Composite Nanoparticles

Cat. No. Product Name Inquiry
X26-06-ZQ4723 GSH-responsive vancomycin-loaded PLGA nanoparticles surface-modified with triphenylphosphonium (GSH-PLGA(Van)@TPP)
X26-06-ZQ4724 ROS-responsive vancomycin-loaded PLGA nanoparticles surface-modified with mannose (ROS-PLGA(Van)@Mannose)
X26-06-ZQ4725 Vancomycin-loaded PLGA nanoparticles surface-modified with GE11 peptide (PLGA(Van)@GE11)
X26-06-ZQ4726 Vancomycin-loaded PLGA nanoparticles surface-modified with polyethyleneimine (PLGA(Van)@PEI)
X26-06-ZQ4727 Vancomycin-loaded PLGA nanoparticles surface-modified with folic acid (PLGA(Van)@FA)
X26-06-ZQ4728 Vancomycin-loaded PLGA nanoparticles surface-modified with galactose (PLGA(Van)@Galactose)
X26-06-ZQ4729 ROS-responsive vancomycin-loaded PLGA nanoparticles surface-modified with GE11 peptide (ROS-PLGA(Van)@GE11)
X26-06-ZQ4730 ROS-responsive Cyanine 5.5-labeled vancomycin-loaded PLGA nanoparticles (ROS-PLGA(Van)-Cy5.5)
X26-06-ZQ4731 ROS-responsive vancomycin-loaded PLGA nanoparticles surface-modified with folic acid (ROS-PLGA(Van)@FA)
X26-06-ZQ4732 ROS-responsive NBD-labeled vancomycin-loaded PLGA nanoparticles (ROS-PLGA(Van)-NBD)
X26-06-ZQ4733 ROS-responsive Cyanine 7-labeled vancomycin-loaded PLGA nanoparticles (ROS-PLGA(Van)-Cy7)
X26-06-ZQ4734 ROS-responsive vancomycin-loaded PLGA nanoparticles (100 nm size) (ROS-PLGA(Van))
X26-06-ZQ4735 ROS-responsive FITC-labeled vancomycin-loaded PLGA nanoparticles (ROS-PLGA(Van)-FITC)
X26-06-ZQ4736 Vancomycin-loaded PLGA nanoparticles surface-modified with 7-nitrobenzofurazan (PLGA(Van)@NBD)
X26-06-ZQ4737 ROS-responsive vancomycin-loaded PLGA nanoparticles surface-modified with TAT cell-penetrating peptide (ROS-PLGA(Van)@TAT)
X26-06-ZQ4738 Vancomycin-loaded PLGA nanoparticles surface-modified with TAT cell-penetrating peptide (PLGA(Van)@TAT)
X26-06-ZQ4739 Vancomycin-loaded PLGA nanoparticles surface-modified with mannose (PLGA(Van)@Mannose)
X26-06-ZQ4740 ROS-responsive vancomycin-loaded PLGA nanoparticles surface-modified with polyethyleneimine (ROS-PLGA(Van)@PEI)
X26-06-ZQ4741 ROS-responsive Cyanine 3.5-labeled vancomycin-loaded PLGA nanoparticles (ROS-PLGA(Van)-Cy3.5)
X26-06-ZQ4742 Vancomycin-loaded PLGA nanoparticles surface-modified with NGR peptide (PLGA(Van)@NGR)
X26-06-ZQ4743 ROS-responsive indocyanine green-loaded vancomycin-loaded PLGA nanoparticles (ROS-PLGA(Van/ICG))
X26-06-ZQ4744 Vancomycin-loaded PLGA nanoparticles surface-modified with Cyanine 7 (PLGA(Van)@Cy7)
X26-06-ZQ4745 Vancomycin-loaded PLGA nanoparticles surface-modified with metronidazole (PLGA(Van)@Metronidazole)
X26-06-ZQ4746 ROS-responsive Cyanine 5-labeled vancomycin-loaded PLGA nanoparticles (ROS-PLGA(Van)-Cy5)
X26-06-ZQ4747 ROS-responsive vancomycin-loaded PLGA nanoparticles surface-modified with galactose (ROS-PLGA(Van)@Galactose)
X26-06-ZQ4748 Vancomycin-loaded PLGA nanoparticles surface-modified with Angiopep-2 (PLGA(Van)@Angiopep-2)
X26-06-ZQ4749 Indocyanine green-loaded vancomycin-loaded PLGA nanoparticles (PLGA(Van/ICG))
X26-06-ZQ4750 Vancomycin-loaded PLGA nanoparticles surface-modified with chitosan (PLGA(Van)@Chitosan)
X26-06-ZQ4751 PLGA-encapsulated doxorubicin-loaded mesoporous silica nanoparticles surface-modified with Angiopep-2 (PLGA@MSNs(DOX)@Angiopep-2)
X26-06-ZQ4752 PLGA-encapsulated doxorubicin-loaded mesoporous silica nanoparticles surface-modified with mannose (PLGA@MSNs(DOX)@Mannose)
X26-06-ZQ4753 Rapamycin-loaded PLGA nanoparticles surface-modified with TAT cell-penetrating peptide (PLGA(Rapamycin)@TAT)
X26-06-ZQ4769 Bicalutamide nanoparticles / Bicalutamide nanocrystals
X26-06-ZQ4779 Amine-polyethylene glycol-coated magnetite nanoparticles (200 nm PEG2K-NH2@Fe3O4)
X26-06-ZQ4785 Polyethylene glycol-coated magnetite nanoparticles (20 nm PEG@Fe3O4)
X26-06-ZQ4798 Curcumin-loaded PLGA nanoparticles surface-modified with cRGD (100 nm size) (PLGA(Cur)@cRGD)
X26-06-ZQ4799 Indocyanine green/curcumin co-loaded PLGA nanoparticles (100 nm size) (PLGA(Cur/ICG))
X26-06-ZQ4800 Indocyanine green-labeled doxorubicin-loaded PLGA nanoparticles surface-modified with NGR peptide (PLGA(DOX)-ICG@NGR)
X26-06-ZQ4801 Curcumin-loaded PLGA nanoparticles surface-modified with cRGD (200 nm size) (PLGA(Cur)@cRGD)
X26-06-ZQ4802 Cyanine 3.5-labeled doxorubicin-loaded PLGA nanoparticles surface-modified with NGR peptide (PLGA(DOX)-Cy3.5@NGR)
X26-06-ZQ4803 Cyanine 5.5-labeled doxorubicin-loaded PLGA nanoparticles surface-modified with NGR peptide (PLGA(DOX)-Cy5.5@NGR)

About Us

CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.

Contact Us

  • For research and manufacturing partners only. Not intended for (direct) human or veterinary use.
Copyright © CD BioGlyco. All rights reserved.